Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-902-6 | CAS number: 75-79-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1997
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to the appropriate test guideline, and in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 997
- Report date:
- 1997
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- yes
- Remarks:
- Exposure duration of 1 hour, instead of 4 hours.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Trichloro(methyl)silane
- EC Number:
- 200-902-6
- EC Name:
- Trichloro(methyl)silane
- Cas Number:
- 75-79-6
- Molecular formula:
- CH3Cl3Si
- IUPAC Name:
- trichloro(methyl)silane
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: Approximately 6-7 weeks old
- Weight at study initiation: mean body weights of 130 +/- 25 g (males) and 119 +/- 16 g (females) when exposed
(no other data available)
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- No information available.
- Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- 1 h
- Remarks on duration:
- (after equilibration, T90 = 6 minutes)
- Concentrations:
- 622, 1047, 1439 and 3075 ppm (nominal)
- No. of animals per sex per dose:
- 5/sex/dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were observed immediately following exposure and once a day for fourteen days following exposure for treatment-related signs of toxicity. Signs included but were not limited to evidence of any respiratory, behavioral, nasal and/or ocular changes. In addition, a mortality/morbidity check was performed twice daily on weekdays and once a day on weekends and holidays. Body weights were collected on days 1, 8, and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, other: Gross necropsies were performed on all animals that died during the study or were sacrificed at the end of the observation period. - Statistics:
- LC50 calculation with confident limits reported only.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 1 365 ppm
- 95% CL:
- 1 174 - 2 014
- Exp. duration:
- 1 h
- Mortality:
- Details provided below
- Clinical signs:
- other: Details provided below
- Body weight:
- All surviving animals exposed to 622 and 1047 ppm gained weight during the 14-day observation period. Body weights for surviving animals exposed to 1439 ppm were initially depressed at the end of the first week, but all animals were gaining weight by the end of the observation period.
- Gross pathology:
- There were no gross necropsy findings for all survivors from the 622 and 1047 ppm groups, and for two of the four survivors from the 1439 ppm group. Corneal opacities were noted at the scheduled necropsy for two 1439 ppm rats.
Necropsy findings seen in more than three-quarters of the rats that died included various external staining, lung abnormalities (red/dark red foci, hemorrhage, discoloration, ectasia), discolored/congested or pale livers and corneal opacities. In addition, approximately one-half of the rats that died had hemorrhagic thymus glands, including 6/10 in the 3075 ppm group. Other findings seen in three or fewer rats that died included fluid-filled nostrils, dehydration, gaseous distension of the gastrointestinal tract and a submeningeal hemorrhage. - Other findings:
- - Potential target organs: Test article related gross pathological findings were noted in the lungs (hemorrhage and/or congestion), liver (congestion) and thymus (hemorrhage) in a majority of the animals found dead. Effects on the eyes, nasal region and body condition were also noted in majority of the animals that died during the study. However, at the final sacrifice, no test article related gross pathological effects were noted in the surviving animals.
- Other observations: Responses were generally consistent between males and females.
Any other information on results incl. tables
Table 1: Concentrations, exposure conditions and mortality per animals treated
Nominal Conc. (ppm) |
Mortality (# dead/total) |
||
Males |
Females |
Combined |
|
3075 |
5/5 |
5/5 |
10/10 |
1439 |
4/5 |
2/5 |
6/10 |
1047 |
0/5 |
1/5 |
1/10 |
622 |
0/5 |
0/5 |
0/10 |
Description, severity, time of onset and duration of clinical signs at each dose level:
In the 622 ppm group, lacrimation, red and/or swollen paws and various staining/soiling
around the nose, mouth and/or eyes and other body surfaces were seen in essentially all rats.
The lacrimation and red/swollen paws were generally only noted on the day of exposure.
The staining/soiling was first observed on the day of or the day after exposure and persisted
in various forms for a few days. Salivation was seen on the day of exposure for four 622 ppm
rats and there was a low incidence of red nose, hunched posture and ocular opacity in this group.
No respiratory effects were seen in the 622 ppm group. All rats in this group appeared normal
clinically by day 5 and remained essentially so through study termination.
In the 1047 ppm group, red nose, lacrimation, salivation, red and/or swollen paws and various
staining/soiling around the nose, mouth and/or eyes and other body surfaces were seen in essentially
all rats. Except for the latter, all of these signs were first noted on the day of exposure and were of
short duration. The staining/soiling was first observed on the day of or the day after exposure and
persisted in various forms for several days. Respiratory effects in this group were limited to rales,
observed for three rats on day 2, one of which also exhibited gasping. Eight of the nine survivors in
this group returned to a normal clinical condition five to seven days after exposure and remained
essentially so through study termination.
In the 1439 ppm group, red and/or swollen paws, lacrimation, respiratory distress (labored
breathing, gasping, rales), red nose, reduced activity (variously described as lethargy, hypoactivity
or decreased activity), and various staining/soiling around the nose, mouth and/or eyes and other
body surfaces were seen in a majority of the rats. Except for the staining/soiling, these signs were
generally first seen on the day of or the day after exposure. The red/swollen paws, red nose,
lacrimation and salivation generally did not persist beyond the day of exposure. The respiratory
effects and the staining/soiling tended to persist for a few to several days. Other clinical signsseen at a low incidence (four or fewer rats) in the 1439 ppm group were hunched posture, ocular
opacity, ataxia and emaciation. Three of the four survivors in this group returned to a normal
clinical condition after 11 or 12 days and remained so until study termination.
Clinical signs were very limited in the 3075 ppm group, as seven of these rats were found dead
upon exposure completion. Respiratory distress (gasping, labored breathing), decreased activity,
salivation, red and swollen paws and ocular opacity were seen in all three rats that did not die
during exposure. Other signs in these rats were piloerection, ataxia and hunched posture.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category III
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The one-hour combined male/female LC50, based on nominal concentrations, was determined to be 1365 ppm with 95% confidence limits of 1174-2104 ppm in a reliable study conducted according to an appropriate test protocol and in compliance with GLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.